Sun Pharmaceutical Share Price Target at Rs 2,000: Motilal Oswal Research
Motilal Oswal has reiterated a BUY recommendation on Sun Pharma, assigning a target price of Rs 2,000, implying a 16% upside from its current market price of Rs 1,719. Despite a mixed Q4 FY25 performance, marked by a 4% revenue miss and higher exceptional …